TherapeuticsMD (NASDAQ:TXMD) Coverage Initiated at StockNews.com

Equities research analysts at StockNews.com began coverage on shares of TherapeuticsMD (NASDAQ:TXMD) in a research note issued to investors on Tuesday. The firm set a “hold” rating on the stock.

TherapeuticsMD Stock Up 5.9 %

Shares of TherapeuticsMD stock traded up $0.06 during trading on Tuesday, reaching $0.98. The company’s stock had a trading volume of 26,069 shares, compared to its average volume of 152,325. The company has a 50-day simple moving average of $0.96 and a two-hundred day simple moving average of $1.24. TherapeuticsMD has a 1-year low of $0.70 and a 1-year high of $2.44.

About TherapeuticsMD

TherapeuticsMD, Inc operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors.